MOH Q1 2026: Molina Healthcare Keeps Guidance But Faces Revenue Headwinds

Lead: a quarter that tests the math and the message

In the first quarter ended March 31, 2026, Molina Healthcare, Inc. (NYSE: MOH) reported a GAAP diluted EPS of $0.27 and an adjusted diluted EPS of $2.35. GAAP net income came in at $14 million, contrasting with $298 million in the year-ago quarter. On the top line, premium revenue was $10,172 million for the quarter, down from $10,628 million a year earlier, and total revenue was $10,796 million vs. $11,147 million. The company nevertheless reaffirmed its full-year 2026 revenue forecast and adjusted earnings guidance.

Yes, the press release is full of numbers, but the story is the old finance joke with a new wrapper: adjusted metrics can look friendlier, while GAAP reality insists on showing the work. The EPS discrepancy, along with the revenue declines, invites a closer look at how management intends to navigate payer dynamics and cost structure through the rest of 2026.

Key quarterly numbers (Three months ended March 31)

Premium Revenue: $10,172 million (2025: $10,628 million)

Total Revenue: $10,796 million (2025: $11,147 million)

GAAP Net Income: $14 million (2025: $298 million)

EPS – Diluted: $0.27 (Other quarter data not shown here)

Adjusted EPS: $2.35

All figures are in millions, except per-share results, as reported by Molina.

Interpretation note: the year-over-year comparisons show a meaningful drop in GAAP net income and a softer top line, even as the adjusted EPS line remains elevated by accounting adjustments and ongoing operating metrics.

Guidance and what it signals for 2026

The release reiterates Molina’s reaffirmed revenue forecast for 2026 in terms of premium revenue and adjusted earnings. In practice, that means management sees ongoing efficiency or favorable mix—not yet captured in the quarter’s GAAP results—as enough to support the full-year targets. For investors, the question is whether the adjusted figure is an emblem of underlying operating leverage or simply a cushion against continued headwinds to premiums and utilization.

The narrative suggests a test: will the first-quarter softness fade as the year progresses, or will the company need to rely more on cost controls and mix shifts to deliver the expected EPS consensus and revenue forecast trajectory?

Implications for Molina and sector peers

MOH’s Q1 backdrop—revenue declines alongside a durable yet elevated adjusted EPS figure—highlights a familiar tension in managed care: how to translate payer negotiations and cost management into sustainable earnings growth. If the earnings surprise risk persists in GAAP terms, the stock could trade more on the quality of the EPS consensus for the year than on a single quarterly beat.

Peers in the space will watch how Molina converts the adjusted earnings narrative into real cash flow and margin improvement. A successful pass through the rest of 2026 would reinforce a broader thesis that disciplined SG&A, more favorable product mix, or better risk adjustment can cushion the sector against premium-rate pressure and regulatory shifts.

Notes and caveats

All figures above reflect the three months ended March 31, 2026, vs. 2025, as presented in Molina Healthcare’s EX-99.1 press release. The document emphasizes GAAP versus adjusted metrics, and readers will naturally compare these results against EPS consensus estimates and the revenue forecast for 2026 as analysts update models.